Treatment Refractory MAC Lung Disease clinical trials at University of California Health
2 in progress, 1 open to eligible people
Showing trials for
ICoN-1 Phase 3 Study of the Efficacy and Safety of Treatment with MNKD-101, Clofazimine Inhalation Suspension
open to eligible people ages 18-85
This clinical trial is designed to compare the efficacy and safety of Clofazimine Inhalation Suspension versus placebo when added to guideline-based therapy (GBT)
at UC Davis UCSF
Epetraborole in Patients With Treatment-refractory MAC Lung Disease
Sorry, in progress, not accepting new patients
This is a pivotal Phase 2/3, double-blind, placebo-controlled study of epetraborole + OBR (Optimized Background Regimen) versus placebo + OBR in patients with treatment-refractory MAC lung disease. This study will enroll adult patients with…
at UCSF
Last updated: